The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients
Condition: Thrombocytopenia Intervention: Drug: Hetrombopag Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Ovarian Cancer | Ovaries | Research | Thrombocytopenia